MODY (Maturity Onset Diabetes of the Young) is a type of diabetes resulting from a pathogenic effect of gene mutations. Up to date, 13 MODY genes are known. Gene HNF1A is one of the most common causes of MODY diabetes (HNF1A-MODY; MODY3). This gene is polymorphic and more than 1200 pathogenic and non-pathogenic HNF1A variants were described in its UTRs, exons and introns. For HNF1A-MODY, not just gene but also phenotype heterogeneity is typical. Although there are some clinical instructions, HNF1A-MODY patients often do not meet every diagnostic criteria or they are still misdiagnosed as type 1 and type 2 diabetics. There is a constant effort to find suitable biomarkers to help with in distinguishing of MODY3 from Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D). DNA sequencing is still necessary for unambiguous confirmation of clinical suspicion of MODY. NGS (Next Generation Sequencing) methods brought discoveries of multiple new gene variants and new instructions for their pathogenicity classification were required. The most actual problem is classification of variants with uncertain significance (VUS) which is a stumbling-block for clinical interpretation. Since MODY is a hereditary disease, DNA analysis of family members is helpful or even crucial. This review is updated summary about HNF1A-MODY genetics, pathophysiology, clinics functional studies and variant classification.
If the inline PDF is not rendering correctly, you can download the PDF file here.
Abdul-Rasoul M Habib H Al-Khouly M. ‘The honeymoon phase’ in children with type 1 diabetes mellitus: Frequency duration and influential factors. Pediatr Diabetes 7 101–107 2006.
Albert MA Danielson E Rifai N Ridker PM. Effect of statin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. J Am Med Assoc 286 64–70 2001.
Armendariz AD Krauss RM. Hepatic nuclear factor 1-α: Inflammation genetics and atherosclerosis. Curr Opin Lipidol 20 106–111 2009.
Awa WL Thon A Raile K Grulich-Henn J Meissner T Schober E Holl RW. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database. Eur J Endocrinol 164 513–520 2011.
Bach I Galcheva-Gargova Z Mattei MG Simon-Chazottes D Guenet JL Cereghini S Yaniv M. Cloning of human hepatic nuclear factor 1 (HNF1) and chromosomal localization of its gene in man and mouse. Genomics 8 155–164 1990.
Bacon S Engelbrecht B Schmid J Pfeiffer S Gallagher R McCarthy A Burke M Concannon C Prehn JH Byrne MM. MicroRNA-224 is readily detectable in urine of individuals with diabetes mellitus and is a potential indicator of beta-cell demise. Genes (Basel) 6 399–416 2015.
Bacon S Kyithar MP Schmid J Pozza AC Handberg A Byrne MM. Circulating CD36 is reduced in HNF1A-MODY carriers. PloS one 8 e74577 2013.
Ban N Yamada Y Someya Y Miyawaki K Ihara Y Hosokawa M Toyokuni S Tsuda K Seino Y. Hepatocyte nuclear factor-1alpha recruits the transcriptional co-activator p300 on the GLUT2 gene promoter. Diabetes 51 1409–1418 2002.
Baumhueter S Mendel DB Conley PB Kuo CJ Turk C Graves MK Edwards CA Courtois G Crabtree GR. HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes Dev 4 372–379 1990.
Bazalova Z Rypackova B Broz J Brunerova L Polak J Rusavy Z Treslova L Andel M. Three novel mutations in MODY and its phenotype in three different Czech families. Diabetes Res Clin Pract 88 132–138 2010.
Bellanne-Chantelot C Carette C Riveline JP Valero R Gautier JF Larger E Reznik Y Ducluzeau PH Sola A Hartemann-Heurtier A Lecomte P Chaillous L Laloi-Michelin M Wilhem JM Cuny P Duron F Guerci B Jeandidier N Mosnier-Pudar H Assayag M Dubois-Laforgue D Velho G Timsit J. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 57 503–508 2008.
Bellanne-Chantelot C Coste J Ciangura C Fonfrede M Saint-Martin C Bouche C Sonnet E Valero R Levy DJ Dubois-Laforgue D Timsit J. High-sensitivity C-reactive protein does not improve the differential diagnosis of HNF1A-MODY and familial young-onset type 2 diabetes: A grey zone analysis. Diabetes Metab 42 33–37 2016.
Berg LP Scopes DA Alhaq A Kakkar VV Cooper DN. Disruption of a binding site for hepatocyte nuclear factor 1 in the protein C gene promoter is associated with hereditary thrombophilia. Hum Mol Genet 3 2147–2152 1994.
Bjorkhaug L Sagen JV Thorsby P Sovik O Molven A Njolstad PR. Hepatocyte nuclear factor-1α gene mutations and diabetes in Norway. J Clin Endocrinol Metab 88 920–931 2003.
Bluteau O Jeannot E Bioulac-Sage P Marques JM Blanc JF Bui H Beaudoin JC Franco D Balabaud C LaurentPuig P Zucman-Rossi J. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet 32 312–315 2002.
Boj SF Parrizas M Maestro MA Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci 98 14481–14486 2001.
Boj SF Petrov D Ferrer J. Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1α and Hnf4α. PLoS Genet 6 5 2010.
Bonner C Nyhan KC Bacon S Kyithar MP Schmid J Concannon CG Bray IM Stallings RL Prehn JHM Byrne MM. Identification of circulating microRNAs in HNF1A-MODY carriers. Diabetologia 56 1743–1751 2013.
Borowiec M Antosik K Fendler W Deja G Jarosz-Chobot P Mysliwiec M Zmyslowska A Malecki M Szadkowska A Mlynarski W. Novel glucokinase mutations in patients with monogenic diabetes clinical outline of GCK-MD and potential for founder effect in Slavic population. Clin Genet 81 278–283 2012.
Borowiec M Liew CW Thompson R Boonyasrisawat W Hu J Mlynarski WM El Khattabi I Kim SH Marselli L Rich SS Krolewski AS Bonner-Weir S Sharma A Sale M Mychaleckyj JC Kulkarni RN Doria A. Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction. Proc Natl Acad Sci 106 14460–14465 2009.
Brantjes H Roose J van De Wetering M Clevers H. All Tcf HMG box transcription factors interact with Grouchorelated co-repressors. Nucleic Acids Res 29 1410–1419 2001.
Brial F Lussier CR Boudreau F. Loss of Hnf1a causes diabetes through enteroendocrine ghrelin upregulationin. Gastroenterology 144 S-34 2013.
Bulla G Fournier RE. Genetic analysis of a transcriptional activation pathway by using hepatoma cell variants. Mol Cell Biol 14 7086–7094 1994.
Byrne MM Sturis J Menzel S Yamagata K Fajans SS Dronsfleld MJ Bain SC Hattersley AT Velho G Froguel P Bell GI Polonsky KS. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45 1503–1510 1996.
Carbon S Ireland A Mungall CJ Shu S Marshall B Lewis S Hub A Presence W Group W. AmiGO: online access to ontology and annotation data. Bioinforma Appl NOTE 25 288–289 2009.
Chambers JC Zhang W Sehmi J Li X Wass MN Van der Harst P Holm H Sanna S Kavousi M Baumeister SE Coin LJ Deng G Gieger C Heard-Costa NL Hottenga JJ Kuhnel B Kumar V Lagou V Liang L et al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet 43 1131–1138 2011.
Chi YI Frantz JD Oh BC Hansen L Dhe-Paganon S Shoelson SE. Diabetes mutations delineate an atypical POU domain in HNF-1α. Mol Cell 10 1129–1137 2002.
Chi YI Frantz JD Oh BC Hansen L Dhe-Paganon SShoelson SE. Diabetes mutations delineate an atypical POU domain in HNF-1alpha. Mol Cell 10 1129–1137 2002.
Chi YI. Homeodomain revisited: a lesson from disease-causing mutations. Hum Genet 116 433–444 2005.
Chiu KC Chuang LM Ryu JM Tsai GP Saad MF. The I27L amino acid polymorphism of hepatic nuclear factor-1α is associated with insulin resistance. J Clin Endocrinol Metab 85 2178–2183 2000.
Cleary M Pendergrast PS Herr W. Structural flexibility in transcription complex formation revealed by proteinDNA photocrosslinking. Proc Natl Acad Sci U S A 94 8450–8455 1997.
Colclough K Bellanne-Chantelot C Saint-Martin C Flanagan SE Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat 34 669–685 2013.
Corrales PJP Lopez Garrido MP Rodriguez SA Rubio LL Lopez Jimenez LM Oliveira CL Alfaro Martinez JJ Lozano Garcia JJ Lopez AH Castillo RR Martinez JE Romero FB. Clinical differences between patients with MODY-3 MODY-2 and type 2 diabetes mellitus with I27L polymorphism in the HNF1α gene. Endocrinol Nut 57 4–8 2010.
Costa RH Kalinichenko VV Holterman AXL Wang X. Transcription factors in liver development differentiation and regeneration. Hepatology 38 1331–1347 2003.
Courtois G Baumhueter S Crabtree GR. Purified hepatocyte nuclear factor 1 interacts with a family of hepatocytespecific promoters. Proc Natl Acad Sci U S A 85 7937–7941 1988.
D’Angelo A Bluteau O Garcia-Gonzalez MA Gresh L Doyen A Garbay S Robine S Pontoglio M. Hepatocyte nuclear factor 1 and control terminal differentiation and cell fate commitment in the gut epithelium. Development 137 1573–1582 2010.
Dalgleish R Flicek P Cunningham F Astashyn A Tully RE Proctor G Chen Y McLaren WM Larsson P Vaughan BW Beroud C Dobson G Lehvaslaiho H Taschner PE den Dunnen JT Devereau A Birney E Brookes AJ Maglott DR. Locus Reference Genomic sequences: an improved basis for describing human DNA variants. Genome Med 2 24 2010.
De Vas MG Kopp JL Heliot C Sander M Cereghini S Haumaitre C. Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors. Development 142 871–882 2015.
Divine JK Staloch LJ Haveri H Jacobsen CM Wilson DB Heikinheimo M Simon TC. GATA-4 GATA-5 and GATA-6 activate the rat liver fatty acid binding protein gene in concert with HNF-1alpha. Am J Physiol Gastrointest Liver Physiol 287 G1086–G1099 2004.
Dohda T Kaneoka H Inayoshi Y Kamihira M Miyake K Iijima S. Transcriptional coactivators CBP and p300 cooperatively enhance HNF-1alpha-mediated expression of the albumin gene in hepatocytes. J Biochem 136 313–319 2004.
Dukes ID Sreenan S Roe MW Levisetti M Zhou YP Ostrega D Bell GI Pontoglio M Yaniv M Philipson L Polonsky KS. Defective pancreatic beta-cell glycolytic signaling in hepatocyte nuclear factor-1alpha-deficient mice. J Biol Chem 273 24457–24464 1998.
Dusatkova P Pruhova S Sumnik Z Kolouskova S Obermannova B Lebl J. HNF1A mutation presenting with fetal macrosomia and hypoglycemia in childhood prior to onset of overt diabetes. J Pediatr Endocr Met 24 377–379 2011.
Eastman Q Grosschedl R. Regulation of LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin Cell Biol 11 233–240 1999.
Edlund H. Transcribing pancreas. Diabetes 47 1817–1823 1998.
Eeckhoute J Formstecher P Laine B. Hepatocyte nuclear factor 4α enhances the hepatocyte nuclear factor 1α-mediated activation of transcription. Nucleic Acids Res 32 2586–2593 2004.
Eide S Rder H Johansson S Midthjell K Svik O Njlstad PR Molven A. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med 25 775–781 2008.
Ellard S Bellanne-Chantelot C Hattersley AT. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51 546–553 2008.
Ellard S Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 27 854–869 2006.
Estrada K Aukrust I Bjorkhaug L Burtt NP Mercader JM Garcia-Ortiz H Huerta-Chagoya A Moreno-Macias H Walford G Flannick J Williams AL Gomez-Vazquez MJ Fernandez-Lopez JC Martinez-Hernandez A Centeno-Cruz F Mendoza-Caamal E Revilla-Monsalve C Islas-Andrade S Cordova EJ et al. Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population. JAMA 311 2305 2014.
Ewing RM Chu P Elisma F Li H Taylor P Climie S McBroom-Cerajewski L Robinson MD O’Connor L Li M Taylor R Dharsee M Ho Y Heilbut A Moore L Zhang S Ornatsky O Bukhman YV Ethier M Sheng Y Vasilescu J Abu-Farha M Lambert JP Duewel HS Stewart II Kuehl B Hogue K Colwill K Gladwish K Muskat B Kinach R Adams SL Moran MF Morin GB Topaloglou T Figeys D. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 3 89 2007.
Fagerberg L Hallstrom BM Oksvold P Kampf C Djureinovic D Odeberg J Habuka M Tahmasebpoor S Danielsson A Edlund K Asplund A Sjostedt E Lundberg E Szigyarto CAK Skogs M Takanen JO Berling H Tegel H Mulder J et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics 13 397–406 2014.
Fahey ME Bennett MJ Mahon C Jager S Pache L Kumar D Shapiro A Rao K Chanda SK Craik CS Frankel AD Krogan NJ. GPS-Prot: A web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinformatics 12 298 2011.
Fajans S Bell G Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345 971–980 2001.
Fernandez-Zapico ME van Velkinburgh JC Gutierrez-Aguilar R Neve B Froguel P Urrutia R Stein R. MODY7 gene KLF11 is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells. J Biol Chem 284 36482–36490 2009.
Ferrer J. A genetic switch in pancreatic β-cells: implications for differentiation and haploinsufficiency. Diabetes 51 2355–2362 2002.
Fokkema IFAC Taschner PEM Schaafsma GCP Celli J Laros JFJ den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat 32 557–563 2011.
Froguel P Velho G. Molecular genetics of maturity-onset diabetes of the young. Trends Endocrinol Metab 10 142–146 1999.
Funk WD Wright WE. Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix nuclear factor 1 myocyte-specific enhancer-binding factor 2 and COMP1 factor. Proc Natl Acad Sci U S A 89 9484–9488 1992.
Galan M Garcia-Herrero CM Azriel S Gargallo M Duran M Gorgojo JJ Andia VM Navas MA. Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation. Mol Med 17 256–265 2011.
Gaulton KJ Ferreira T Lee Y Raimondo A Magi R Reschen ME Mahajan A Locke A William Rayner N Robertson N Scott RA Prokopenko I Scott LJ Green T Sparso T Thuillier D Yengo L Grallert H Wahl S et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet 47 1415–1425 2015.
Geer LY Marchler-Bauer A Geer RC Han L He J He S Liu C Shi W Bryant SH. The NCBI BioSystems database. Nucleic Acids Res 38 492–496 2009.
Godart F Bellanne-Chantelot C Clauin S Gragnoli C Abderrahmani A Blanche H Boutin P Chevre JC Froguel P Bailleul B. Identification of seven novel nucleotide variants in the hepatocyte nuclear factor-1α (TCF1) promoter region in MODY patients. Hum Mutat 15 173–180 2000.
Gragnoli C Lindner T Cockburn BN Kaisaki PJ Gragnoli F Marozzi G Bell GI. Maturity-onset diabetes of the young due to a mutation in the hepatocyte nuclear factor-4 alpha binding site in the promoter of the hepatocyte nuclear factor-1 alpha gene. Diabetes 46 1648–1651 1997.
Grimm AA Brace CS Wang T Stormo GD Imai S. A nutrient-sensitive interaction between Sirt1 and HNF-1alpha regulates Crp expression. Aging Cell 10 305–317 2011.
Harries LW Brown JE Gloyn AL. Species-specific differences in the expression of the HNF1A HNF1B and HNF4A genes. PLoS One 4 2009.
Harries LW Ellard S Stride A Morgan NG Hattersley AT Vaxillaire M Tuomi T Barbetti E Njolstad PR Hansen T Costa A Congret I Pedersen O Sovik O Lorini R Froguel P. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 15 2216–2224 2006.
Hegele RA Cao H Harris SB Hanley AJG Zinman B. The hepatic nuclear factor-1α G319S variant is associated with early-onset Type 2 diabetes in Canadian Oji-Cree. J Clin Endocrinol Metab 84 1077–1082 1999.
Hiraiwa H Pan CJ Lin B Akiyama TE Gonzalez FJ Chou JY. A molecular link between the common phenotypes of Type 1 glycogen storage disease and HNF1α-null mice. J Biol Chem 276 7963–7967 2001.
Holmkvist J Cervin C Lyssenko V Winckler W Anevski D Cilio C Almgren P Berglund G Nilsson P Tuomi T Lindgren CM Altshuler D Groop L. Common variants in HNF-1 α and risk of type 2 diabetes. Diabetologia 49 2882–2891 2006.
Hoskins JW Jia J Flandez M Parikh H Xiao W Collins I Emmanuel MA Ibrahim A Powell J Zhang L Malats N Bamlet WR Petersen GM Real FX Amundadottir LT. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Carcinogenesis 35 2670–2678 2014.
Hua Q Zhao M Narayana N Nakagawa SH Jia W Weiss MA. Diabetes-associated mutations in a beta -cell transcription factor destabilize an antiparallel ‘mini-zipper’ in a dimerization interface. Proc Natl Acad Sci 97 1999–2004 2000.
Ishigaki K Namba H Nakashima M Nakayama T Mitsutake N Hayashi T Maeda S Ichinose M Kanematsu T Yamashita S. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 87 3433–3440 2002.
Ishii Y Hansen AJ Mackenzie PI. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter. Mol Pharmacol 57 940–947 2000.
Jacquemin P Lemaigre FP Rousseau GG. The Onecut transcription factor HNF-6 (OC-1) is required for timely specification of the pancreas and acts upstream of Pdx-1 in the specification cascade. Dev Biol 258 105–116 2003.
Jeannot E Mellottee L Bioulac-Sage P Balabaud C Scoazec JY Van Nhieu JT Bacq Y Michalak S Buob D LaurentPuig P Rusyn I Zucman-Rossi J. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 59 1836–1844 2010.
Kathiresan S Willer CJ Peloso GM Demissie S Musunuru K Schadt EE Kaplan L Bennett D Li Y Tanaka T Voight BF Bonnycastle LL Jackson AU Crawford G Surti A Guiducci C Burtt NP Parish S Clarke R et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41 56–65 2009.
Kherra S Blouin JL Santoni F Schwitzgebel V. Precision medicine for monogenic diabetes: from a survey to the development of a next-generation diagnostic panel. Swiss Med Wkly 147 w14535 2017.
Klupa T Warram JH Antonellis A Pezzolesi M Nam M Malecki MT Doria A Rich SS Krolewski AS. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. Diabetes Care 25 2292–2301 2002.
Koepsell H Lips K Volk C. Polyspecific organic cation transporters: structure function physiological roles and biopharmaceutical implications. Pharm Res 24 1227–1251 2007.
Kohler S Vasilevsky NA Engelstad M Foster E McMurry J Ayme S Baynam G Bello SM Boerkoel CF Boycott KM Brudno M Buske OJ Chinnery PF Cipriani V Connell LE Dawkins HJS DeMare LE Devereau AD de Vries BBA et al. The human phenotype ontology in 2017.Nucleic Acids Res 45 D865–D876 2017.
Kotlyar M Pastrello C Sheahan N Jurisica I. Integrated interactions database: tissue-specific view of the human and model organism interactomes. Nucleic Acids Res 44 D536–D541 2016.
Kritis AA Ktistaki E Barda D Zannis VI Talianidis L. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. Nucleic Acids Res 21 5882–5889 1993.
Kuo CJ Conley PB Chen L Sladek FM Darnell JE Crabtree GR. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355 457–461 1992.
Lau HH Ng NHJ Loo LSW Jasmen JB Teo AKK. The molecular functions of hepatocyte nuclear factors – In and beyond the liver. J Hepatol 68 1033–1048 2018.
Lausen J Thomas H Lemm I Bulman M Borgschulze M Lingott A Hattersley AT Ryffel GU. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 28 430–437 2000.
Lebenthal Y Fisch Shvalb N Gozlan Y Tenenbaum A Tenenbaum-Rakover Y Vaillant E Froguel P Vaxillaire M Gat-Yablonski G. The unique clinical spectrum of maturity onset diabetes of the young type 3. Diabetes Res Clin Pract 135 18–22 2018.
Lee YH Sauer B Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol 18 3059–3068 1998.
Lek M Karczewski KJ Minikel EV Samocha KE Banks E Fennell T O’Donnell-Luria AH Ware JS Hill AJ Cummings BB Tukiainen T Birnbaum DP Kosmicki JA Duncan LE Estrada K Zhao F Zou J Pierce-Hoffman E Berghout J et al. Analysis of protein-coding genetic variation in 60706 humans. Nature 536 285–291 2016.
Leu JI Crissey MA Leu JP Ciliberto G Taub R. Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes an adaptive response to liver injury. Mol Cell Biol 21 414–424 2001.
Ley SH Hegele RA Connelly PW Harris SB Mamakeesick M Cao H Gittelsohn J Retnakaran R Zinman B Hanley AJ. Assessing the association of the HNF1A G319S variant with C-reactive protein in Aboriginal Canadians: A population-based epidemiological study. Cardiovasc Diabetol 9 1–6 2010.
Li J Ning G Duncan SA. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev 14 464–474 2000.
Lim S Jin K Friedman E. Mirk protein kinase is activated by MKK3 and functions as a transcriptional activator of HNF1alpha. J Biol Chem 277 25040–25046 2002.
Luni C Marth JD Doyle FJ. Computational Modeling of Glucose Transport in Pancreatic β-Cells Identifies Metabolic Thresholds and Therapeutic Targets in Diabetes. PLoS One 7 e53130 2012.
Luo Z Li Y Wang H Fleming J Li M Kang Y Zhang R Li D. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer. PLoS One 10 e0121082 2015.
Lussier CR Brial F Roy SAB Langlois MJ Verdu EF Rivard N Perreault N Boudreau F. Loss of hepatocyte-nuclearfactor-1α impacts on adult mouse intestinal epithelial cell growth and cell lineages differentiation. PLoS One 5 e12378 2010.
MacArthur J Bowler E Cerezo M Gil L Hall P Hastings E Junkins H McMahon A Milano A Morales J Pendlington ZM Welter D Burdett T Hindorff L Flicek P Cunningham F Parkinson H. The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res 45 D896–D901 2017.
Magee TR Cai Y El-Houseini ME Locker J Wan YJ. Retinoic acid mediates down-regulation of the alpha-fetoprotein gene through decreased expression of hepatocyte nuclear factors. J Biol Chem 273 30024–30032 1998.
Majidi S Fouts A Pyle L Chambers C Armstrong T Wang Z Batish SD Klingensmith G Steck AK. Can biomarkers help target maturity-onset diabetes of the young genetic testing in antibody-negative diabetes? Diabetes Technol Ther 20 106–112 2018.
McDonald TJ Colclough K Brown R Shields B Shepherd M Bingley P Williams A Hattersley AT Ellard S. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type1 diabetes. Diabet Med 28 1028–1033 2011a.
McDonald TJ Ellard S. Maturity onset diabetes of the young: Identification and diagnosis. Ann Clin Biochem 50 403–415 2013.
McDonald TJ McEneny J Pearson ER Thanabalasingham G Szopa M Shields BM Ellard S Owen KR Malecki MT Hattersley AT Young IS. Lipoprotein composition in HNF1A-MODY: Differentiating between HNF1AMODY and Type 2 diabetes. Clin Chim Acta 413 927–932 2012.
McDonald TJ Shields BM Lawry J Owen KR Gloyn AL Ellard S Hattersley AT. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 34 1860–1862 2011b.
Mendel D Crabtree G. Hnf-1 a member of a novel class of dimerizing homeodomain proteins. J Biol Chem 266 677–680 1991.
Mendel DB Hansen LP Graves MK Conley PB Crabtree GR. HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains but not activation domains and form heterodimers in vitro. Genes Dev 5 1042–1056 1991.
Mendel DB Khavari PA Conley PB Graves MK Hansen LP Admon A Crabtree GR. Characterization of a cofactor that regulates dimerization of a mammalian homeodomain protein. Science 254 1762–1767 1991.
Miles RR Crockett DK Lim MS Elenitoba-Johnson KS. Analysis of BCL6-interacting proteins by tandem mass spectrometry. Mol Cell Proteomics 4 1898–1909 2005.
Mitchelmore C Troelsen JT Spodsberg N Sjostrom H Noren O. Interaction between the homeodomain proteins Cdx2 and HNF1alpha mediates expression of the lactase-phlorizin hydrolase gene. Biochem J 346 Pt 2 529–535 2000.
Miyamoto-Sato E Fujimori S Ishizaka M Hirai N Masuoka K Saito R Ozawa Y Hino K Washio T Tomita M Yamashita T Oshikubo T Akasaka H Sugiyama J Matsumoto Y Yanagawa H. A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One 5 e9289 2010.
Mrozinska S Radkowski P Gosiewski T Szopa M Bulanda M Ludwig-Galezowska AH Morawska I Sroka-Oleksiak A Matejko B Kapusta P Salamon D Malecki MT Wolkow P Klupa T. Qualitative parameters of the colonic flora in patients with HNF1A-MODY are different from those observed in Type 2 diabetes mellitus. J Diabetes Res 2016 1–9 2016.
Mughal SA Park R Nowak N Gloyn AL Karpe F Matile H Malecki MT Mccarthy MI Stoffel M Owen KR. Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes. Diabet Med 30 246–250 2013.
Najmi LA Aukrust I Flannick J Molnes J Burtt N Molven A Groop L Altshuler D Johansson S Bjorkhaug L Njolstad PR. Functional investigations of HNF1A identify rare variants as risk factors for Type 2 diabetes in the general population. Diabetes 66 335–346 2017.
Nakazato M Murakami N Date Y Kojima M Matsuo H Kangawa K Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 409 194–198 2001.
Nammo T Yamagata K Tanaka T Kodama T Sladek FM Fukui K Katsube F Sato Y Miyagawa J Shimomura I. Expression of HNF-4α (MODY1) HNF-1β (MODY5) and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expr Patterns 8 96–106 2008.
Naqvi AAT Hasan GM Hassan MI. Investigating the role of transcription factors of pancreas development in pancreatic cancer. Pancreatology 18 184–190 2018.
Narayana N Hua QX Weiss MA. The dimerization domain of HNF-1α: Structure and plasticity of an intertwined four-helix bundle with application to diabetes mellitus. J Mol Biol 310 635–658 2001.
Nowak N Hohendorff J Solecka I Szopa M Skupien J Kiec-Wilk B Mlynarski W Malecki MT. Circulating ghrelin level is higher in HNF1A–MODY and GCK–MODY than in polygenic forms of diabetes mellitus. Endocrine 50 643–649 2015.
Nowak N Szopa M Thanabalasingham G McDonald TJ Colclough K Skupien J James TJ Kiec-Wilk B Kozek E Mlynarski W Hattersley AT Owen KR Malecki MT. Cystatin C is not a good candidate biomarker for HNF1A-MODY. Acta Diabetol 50 815–820 2013.
Nyunt O Wu JY McGown IN Harris M Huynh T Leong GM Cowley DM Cotterill AM. Investigating maturity onset diabetes of the young. Clin Biochem Rev 30 67–74 2009.
O’Brien VP Bokelmann K Ramirez J Jobst K Ratain MJ Brockmoller J Tzvetkov M. Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene. J Pharmacol Exp Ther 347 181–192 2013.
O’Leary NA Wright MW Brister JR Ciufo S Haddad D McVeigh R Rajput B Robbertse B Smith-White B AkoAdjei D Astashyn A Badretdin A Bao Y Blinkova O Brover V Chetvernin V Choi J Cox E Ermolaeva O et al. Reference sequence (RefSeq) database at NCBI: current status taxonomic expansion and functional annotation. Nucleic Acids Res 44 D733–D745 2016.
Odom DT Zizlsperger H Gordon DB Bell GW Rinaldi NJ Murray HL Volkert TL Schreiber J Rolfe PA Gifford DK Fraenkel E Bell GI Young RA. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 1378–1381 2004.
Oram RA Jones AG Besser REJ Knight BA Shields BM Brown RJ Hattersley AT McDonald TJ. The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57 187–191 2014.
Owen K Thanabalasingham G Juszczak A. Biomarkers for MODY subtypes [internet]. Diapedia 4104526113 rev. no. 29 2014. Available from: https://doi.org/10.14496/dia.4104526113.29
Owen KR Thanabalasingham G James TJ Karpe F Farmer AJ McCarthy MI Gloyn AL. Assessment of highsensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 33 1919–1924 2010.
Parrizas M Maestro MA Boj SF Paniagua A Casamitjana R Gomis R Rivera F Ferrer J. Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 21 3234–3243 2001.
Pavic T Juszczak A Pape Medvidovic E Burrows C Sekerija M Bennett AJ Cuca Knezevic J Gloyn AL Lauc G McCarthy MI Gornik O Owen KR. Maturity onset diabetes of the young due to HNF1A variants in Croatia. Biochemia medica 28 1–11 2018.
Pearson ER Liddell WG Shepherd M Corrall RJ Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 17 543–545 2000.
Pearson ER Starkey BJ Powell RJ Gribble FM Clark PM Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362 1275–1281 2003.
Pierce BL Ahsan H. Genome-wide ‘pleiotropy scan’ identifies HNF1A region as a novel pancreatic cancer susceptibility locus. Cancer Res 71 4352–4358 2011.
Plengvidhya N Kooptiwut S Songtawee N Doi A Furuta H Nishi M Nanjo K Tantibhedhyangkul W Boonyasrisawat W Yenchitsomanus PT Doria A Banchuin N. PAX4 mutations in Thais with maturity onset diabetes of the young. J Clin Endocrinol Metab 92 2821–2826 2007.
Pontoglio M Barra J Hadchouel M Doyen A Kress C Bach JP Babinet C Yaniv M. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction phenylketonuria and renal Fanconi syndrome. Cell 84 575–585 1996.
Pontoglio M Prie D Cheret C Doyen A Leroy C Froguel P Velho G Yaniv M Friedlander G. HNF1α controls renal glucose reabsorption in mouse and man. EMBO Rep 1 359–365 2000.
Pontoglio M Sreenan S Roe M Pugh W Ostrega D Doyen A Pick AJ Baldwin A Velho G Froguel P Levisetti M Bonner-Weir S Bell GI Yaniv M Polonsky KS. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. J Clin Invest 101 2215–2222 1998.
Prudente S Jungtrakoon P Marucci A Ludovico O Buranasupkajorn P Mazza T Hastings T Milano T Morini E Mercuri L Bailetti D Mendonca C Alberico F Basile G Romani M Miccinilli E Pizzuti A Carella M Barbetti F et al. Loss-of-function mutations in APPL1 in familial diabetes mellitus. Am J Hum Genet 97 177–185 2015.
Pruhova S Dusatkova P Neumann D Hollay E Cinek O Lebl J Sumnik Z. Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration: is it time to change the diagnostic criteria for MODY? Diabetes Care 36 2573–2574 2013.
Pruhova S Dusatkova P Sumnik Z Kolouskova S Pedersen O Hansen T Cinek O Lebl J. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes 11 529–535 2010.
Qin J Zhai J Hong R Shan S Kong Y Wen Y Wang Y Liu J Xie Y. Prospero-related homeobox protein (Prox1) inhibits hepatitis B virus replication through repressing multiple cis regulatory elements. J Gen Virol 90 1246–1255 2009.
Rebouissou S Vasiliu V Thomas C Bellanne-Chantelot C Bui H Chretien Y Timsit J Rosty C Laurent-Puig P Chauveau D Zucman-Rossi J. Germline hepatocyte nuclear factor 1α and 1β mutations in renal cell carcinomas. Hum Mol Genet 14 603–614 2005.
Reiner AP Barber MJ Guan Y Ridker PM Lange LA Chasman DI Walston JD Cooper GM Jenny NS Rieder MJ Durda JP Smith JD Novembre J Tracy RP Rotter JI Stephens M Nickerson DA Krauss RM. Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1α are associated with C-reactive protein. Am J Hum Genet 82 1193–1201 2008.
Ress A Moelling K. Bcr interferes with beta-catenin-Tcf1 interaction. FEBS Lett 580 1227–1230 2006.
Rho H Jones CN Rose RB. Kinetic stability may determine the interaction dynamics of the bifunctional protein DCoH1 the dimerization cofactor of the transcription factor HNF-1alpha. Biochemistry 49 10187–10197 2010.
Richards S Aziz N Bale S Bick D Das S Gastier-Foster J Grody WW Hegde M Lyon E Spector E Voelkerding K Rehm HL. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17 405–424 2015.
Rose RB Bayle JH Endrizzi JA Cronk JD Crabtree GR Alber T. Structural basis of dimerization coactivator recognition and MODY3 mutations in HNF-1α. Nat Struct Biol 7 744–748 2000a.
Rose RB Endrizzi JA Cronk JD Holton J Alber T. High-resolution structure of the HNF-1α dimerization domain. Biochemistry 39 15062–15070 2000b.
Ryffel GU. Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: Functional and pathological consequences. J Mol Endocrinol 27 11–29 2001.
Sabatti C Service SK Hartikainen AL Pouta A Ripatti S Brodsky J Jones CG Zaitlen NA Varilo T Kaakinen M Sovio U Ruokonen A Laitinen J Jakkula E Coin L Hoggart C Collins A Turunen H Gabriel S et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 41 35–46 2009.
Scherer SE Muzny DM Buhay CJ Chen R Cree A Ding Y Dugan-Rocha S Gill R Gunaratne P Harris RA Hawes AC Hernandez J Hodgson AV Hume J Jackson A Khan ZM Kovar-Smith C Lewis LR Lozado RJ et al. The finished DNA sequence of human chromosome 12. Nature 440 346–351 2006.
Schober E Rami B Grabert M Thon A Kapellen T Reinehr T Holl RW. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 26 466–473 2009.
Schwitzgebel VM. Many faces of monogenic diabetes. J Diabetes Investig 5 121–133 2014.
Shah N Thanabalasingham G Owen KR James TJ. Comparability of high-sensitivity CRP methods to detect maturity-onset diabetes of the young due to HNF1A mutations. Br J Biomed Sci 71 84–85 2014.
Shepherd M Pearson ER Houghton J Salt G Ellard S Hattersley AT. No deterioration in glycemic control in HNF1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 26 3191–3192 2003.
Shepherd M Shields B Ellard S Rubio-Cabezas O Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26 437–441 2009.
Shi TT Yang FY Liu C Cao X Lu J Zhang XL Yuan MX Chen C Yang JK. Angiotensin-converting enzyme 2 regulates mitochondrial function in pancreatic β-cells. Biochem Biophys Res Commun 495 860–866 2018.
Shields BM Colclough K. Towards a systematic nationwide screening strategy for MODY. Diabetologia 60 609–612 2017.
Shields BM Hicks S Shepherd MH Colclough K Hattersley AT Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53 2504–2508 2010.
Shields BM McDonald TJ Ellard S Campbell MJ Hyde C Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55 1265–1272 2012.
Shih D Bussen M Sehayek E. Hepatocyte nuclear factor-1 is an essential regulator of bile acid and plasma cholesterol metabolism. Nature 27 379–382 2001a.
Shih D Screenan S Munoz K Diabetes LP. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50 2472–2480 2001b.
Shih DQ Stoffel M. Dissecting the transcriptional network of pancreatic islets during development and differentiation. Proc Natl Acad Sci 98 14189–14191 2001.
Shu Y Sheardown SA Brown C Owen RP Zhang S Castro RA Ianculescu AG Yue L Lo JC Burchard EG Brett CM Giacomini KM. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 117 1422–1431 2007.
Simaite D Kofent J Gong M Ruschendorf F Jia S Arn P Bentler K Ellaway C Kuhnen P Hoffmann GF Blau N Spagnoli FM Hubner N Raile K. Recessive mutations in PCBD1 cause a new type of early-onset diabetes. Diabetes 63 3557–3564 2014.
Skupien J Gorczynska-Kosiorz S Klupa T Cyganek K Wanic K Borowiec M Sieradzki J Malecki MT. Molecular background and clinical characteristics of HNF1A MODY in a Polish population. Diabetes Metab 34 524–528 2008.
Sneha P Thirumal KD George PDC Siva R Zayed H. Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach. PLoS One 12 2017.
Soeki T Sata M. Inflammatory biomarkers and atherosclerosis. Int Heart J 57 134–139 2016.
Sourdive DJ Transy C Garbay S Yaniv M. The bifunctional DCOH protein binds to HNF1 independently of its 4-alpha-carbinolamine dehydratase activity. Nucleic Acids Res 25 1476–1484 1997.
Soutoglou E Papafotiou G Katrakili N Talianidis I. Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins. J Biol Chem 275 12515–12520 2000.
Stanescu D Hughes N Kaplan B Stanley C De Leon D. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. J Clin Endocrinol Metab 97 2026–2030 2012.
Stanik J Dusatkova P Cinek O Valentinova L Huckova M Skopkova M Dusatkova L Stanikova D Pura M Klimes I Lebl J Gasperikova D Pruhova S. De novo mutations of GCK HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia 57 480–484 2014.
Steele AM Shields BM Shepherd M Ellard S Hattersley AT Pearson ER. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med 27 157–161 2010.
Stenson PD Mort M Ball EV Shaw K Phillips AD Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics diagnostic testing and personalized genomic medicine. Hum Genet 133 1–9 2014.
Stride A Vaxillaire M Tuomi T Barbetti F Njolstad PR Hansen T Costa A Conget I Pedersen O Sovik O Lorini R Groop L Froguel P Hattersley AT. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45 427–435 2002.
Sur I Taipale J. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function. Nat Rev Cancer 110 827–833 2016.
Szklarczyk D Morris JH Cook H Kuhn M Wyder S Simonovic M Santos A Doncheva NT Roth A Bork P Jensen LJ von Mering C. The STRING database in 2017: quality-controlled protein–protein association networks made broadly accessible. Nucleic Acids Res 45 D362–D368 2017.
Szopa M Klupa T Kapusta M Matejko B Ucieklak D Glodzik W Zapala B Sani CM Hohendorff J Malecki MT Skupien J. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations. Endocrine 64 1–7 2019.
Szpirer J Pedeutour F Kesti T Riviere M Syvaoja JE Turc-Carel C Szpirer C. Localization of the gene for DNA polymerase epsilon (POLE) to human chromosome 12q24.3 and rat chromosome 12 by somatic cell hybrid panels and fluorescence in situ hybridization. Genomics 20 223–226 1994.
Taneera J Storm P Groop L. Downregulation of type II diabetes mellitus and maturity onset diabetes of young pathways in human pancreatic islets from hyperglycemic donors. J Diabetes Res 2014 237535 2014.
Thanabalasingham G Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 343 6044 2011.
Thanabalasingham G Shah N Vaxillaire M Hansen T Tuomi T Gasperikova D Szopa M Tjora E James TJ Kokko P Loiseleur F Andersson E Gaget S Isomaa B Nowak N Raeder H Stanik J Njolstad PR Malecki MT et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 54 2801–2810 2011.
Tzvetkov MV Saadatmand AR Bokelmann K Meineke I Kaiser R Brockmoller J. Effects of OCT1 polymorphisms on the cellular uptake plasma concentrations and efficacy of the 5-HT3 antagonists tropisetron and ondansetron. Pharmacogenomics J 12 22–29 2012.
Tzvetkov MV Saadatmand AR Lotsch J Tegeder I Stingl JC Brockmoller J. Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug Tramadol. Clin Pharmacol Ther 90 143–150 2011.
Urbanova J Rypackova B Prochazkova Z Kucera P Cerna M Andel M Heneberg P. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA 1c level. Diabet Med 31 466–471 2014.
van Wering HM Huibregtse IL van der Zwan SM de Bie MS Dowling LN Boudreau F Rings EH Grand RJ Krasinski SD. Physical interaction between GATA-5 and hepatocyte nuclear factor-1alpha results in synergistic activation of the human lactase-phlorizin hydrolase promoter. J Biol Chem 277 27659–27667 2002.
Vaxillaire M Abderrahmani A Boutin P Bailleul B Froguel P Yaniv M Pontoglio M. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 274 35639–35646 1999.
Vaxillaire M Froguel P. Monogenic diabetes: Implementation of translational genomic research towards precision medicine. J Diabetes 8 782–795 2016.
Vesterhus M Haldorsen I Ræder H Molven A Njolstad P. Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young. J Clin Endocrinol Metab 93 3505–3509 2008.
Wang H Maechler P Antinozzi PA Hagenfeldt KA Wollheim CB. Hepatocyte nuclear factor 4α regulates the expression of pancreatic β-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J Biol Chem 275 35953–35959 2000.
Wang J Huo K Ma L Tang L Li D Huang X Yuan Y Li C Wang W Guan W Chen H Jin C Wei J Zhang W Yang Y Liu Q Zhou Y Zhang C Wu Z Xu W Zhang Y Liu T Yu D Zhang Y Chen L Zhu D Zhong X Kang L Gan X Yu X Ma Q Yan J Zhou L Liu Z Zhu Y Zhou T He F Yang X. Toward an understanding of the protein interaction network of the human liver. Mol Syst Biol 7 536 2011.
Wu KJ Wilson DR Shih C Darlington GJ. The transcription factor HNF1 acts with C/EBP alpha to synergistically activate the human albumin promoter through a novel domain. J Biol Chem 269 1177–1182 1994.
Wu B Piloto S Zeng W Hoverter NP Schilling TF Waterman ML. Ring Finger Protein 14 is a new regulator of TCF/β-catenin-mediated transcription and colon cancer cell survival. EMBO Rep 14 347–355 2013.
Wu Y Liu H Shi X Yao Y Yang W Song Y. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma. Oncotarget 6 9160–9172 2015.
Yang Q Yamagata K Yamamoto K Miyagawa J Takeda J Iwasaki N Iwahashi H Yoshiuchi I Namba M Miyazaki J Hanafusa T Matsuzawa Y. Structure/function studies of hepatocyte nuclear factor-1α a diabetes-associated transcription factor. Biochem Biophys Res Commun 266 196–202 1999.
Yang X Song JH Cheng Y Wu W Bhagat T Yu Y Abraham JM Ibrahim S Ravich W Roland BC Khashab M Singh VK Shin EJ Yang X Verma AK Meltzer SJ Mori Y. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut 63 881–890 2014.
Yu M Wang J Li W Yuan YZ Li CY Qian XH Xu WX Zhan YQ Yang XM. Proteomic screen defines the hepatocyte nuclear factor 1alpha-binding partners and identifies HMGB1 as a new cofactor of HNF1alpha. Nucleic Acids Res 36 1209–1219 2008.
Zhu H Leung SW. Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies. Diabetologia 58 900–911 2015.
Zou Y Lim S Lee K Deng X Friedman E. Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M. J Biol Chem 278 49573–49581 2003.